[go: up one dir, main page]

Yamauchi et al., 2014 - Google Patents

Functional differentiation of RAMP2 and RAMP3 in their regulation of the vascular system

Yamauchi et al., 2014

View PDF
Document ID
7470307146840241433
Author
Yamauchi A
Sakurai T
Kamiyoshi A
Ichikawa-Shindo Y
Kawate H
Igarashi K
Toriyama Y
Tanaka M
Liu T
Xian X
Imai A
Zhai L
Owa S
Arai T
Shindo T
Publication year
Publication venue
Journal of molecular and cellular cardiology

External Links

Snippet

Adrenomedullin (AM) is a vasoactive peptide that possesses various bioactivities. AM receptors are dimers consisting of CLR with one of two accessory proteins, RAMP2 or RAMP3. The functional difference between CLR/RAMP2 and CLR/RAMP3 and the …
Continue reading at soar-ir.repo.nii.ac.jp (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups

Similar Documents

Publication Publication Date Title
Yamauchi et al. Functional differentiation of RAMP2 and RAMP3 in their regulation of the vascular system
Bernier-Latmani et al. DLL4 promotes continuous adult intestinal lacteal regeneration and dietary fat transport
Stzepourginski et al. CD34+ mesenchymal cells are a major component of the intestinal stem cells niche at homeostasis and after injury
Ichikawa-Shindo et al. The GPCR modulator protein RAMP2 is essential for angiogenesis and vascular integrity
Lin et al. VEGF‐C/VEGFR‐3 axis protects against pressure‐overload induced cardiac dysfunction through regulation of lymphangiogenesis
Nakaya et al. Cardiac myofibroblast engulfment of dead cells facilitates recovery after myocardial infarction
Kim et al. Klotho may ameliorate proteinuria by targeting TRPC6 channels in podocytes
Plein et al. Neural crest–derived SEMA3C activates endothelial NRP1 for cardiac outflow tract septation
Baumer et al. Vascular endothelial cell–specific phosphotyrosine phosphatase (VE-PTP) activity is required for blood vessel development
Sellitti et al. Regulation of C-type natriuretic peptide expression
JP7190711B2 (en) Epicardium-derived paracrine factors for repairing cardiac tissue
Shindo et al. Regulation of cardiovascular development and homeostasis by the adrenomedullin-RAMP system
Villasenor et al. Rgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetes
JP4993606B2 (en) Vascular structure stabilizer and angiogenic agent targeting RAMP2
CA3211113A1 (en) Lymphangiogenesis promoting factor-expressing fibroblast, and pharmaceutical composition containing same
JPWO2006134692A6 (en) Vascular structure stabilizer and angiogenic agent targeting RAMP2
CN101242830A (en) Nuclear receptor agonists for the treatment of atherosclerosis and/or related cardiovascular diseases
Yang et al. AIBP-CAV1-VEGFR3 axis dictates lymphatic cell fate and controls lymphangiogenesis
Masoud Endothelial Injury and Repair of the Chronic Allograft Vasculopathy of Heart Allografts
Li Identification of Signaling Mechanisms Controlling the Development of Organ-Specific Vascular Networks
Lim Roles Of Vegfc And Vegfr3 In Lymphangiogenesis And Angiogenesis
Riley Modulation of β-cell intrinsic and extrinsic characteristics by CTGF to promote β-cell mass regeneration
Honkonen Adenoviral gene therapy for the stimulation of neovessel growth: new treatment strategies for lymphedema and peripheral ischemia
Hameed The role of Tumour Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL) in Pulmonary Arterial Hypertension.
Engevik The Regulation of Gastric Ulcer Repair